Dotti Patch, Extended Release
Product Images NDC 72162-2032

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Dotti (NDC 72162-2032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Dotti Estradiol Transdermal System 1)

FDA Label Image

4a (Dotti Estradiol Transdermal System 10)

FDA Label Image

4b (Dotti Estradiol Transdermal System 11)

FDA Label Image

4c (Dotti Estradiol Transdermal System 12)

FDA Label Image

4d (Dotti Estradiol Transdermal System 13)

FDA Label Image

4e (Dotti Estradiol Transdermal System 14)

FDA Label Image

4f (Dotti Estradiol Transdermal System 15)

FDA Label Image

4g (Dotti Estradiol Transdermal System 16)

FDA Label Image

2 (Dotti Estradiol Transdermal System 2)

FDA Label Image

Figure 1 (Dotti Estradiol Transdermal System 3)

FDA Label Image

2 (Dotti Estradiol Transdermal System 4)

The text seems to contain some random characters, numbers and letters which do not make any sense. However, towards the end, there is information related to a study about estradiol and placebo indicating that there is a statistically significant difference (p<0.05) between the two. Therefore, this seems to be a study report or some statistical analysis.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 5)

This appears to be a chart or table showing the percentage change from baseline over the course of several weeks for different treatments involving varying doses of Estradiol and a Placebo. Without additional context, it is difficult to determine what condition or study this data is related to.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 6)

The text appears to be a chart showing different treatments and their effects on a certain variable over the course of different weeks. The treatments listed include Estradiol at different doses, as well as a placebo. The change from baseline is also mentioned. Other than that, the text is not clear enough to provide more information.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 7)

The text is a user instruction for DOTTI™, which is a transdermal system used for the delivery of estradiol. It indicates the specific days when the patch should be changed, which are Sun/Wed, Mon/Thu, Tue/Fri, and Wed/Sat. It doesn't provide any additional information beyond these instructions.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 8)

FDA Label Image

3 (Dotti Estradiol Transdermal System 9)

FDA Label Image

Label (Lbl721622032)

This is a description of a transdermal estradiol patch medicine called DOTTI®. The patch delivers 0.025 mg/day of the active ingredient and should be stored between 20°C to 25°C. It is only meant for transdermal use and should be applied immediately after opening the pouch. The medicine should be kept out of the reach of children and the package is not child-resistant. The medicine was relabeled by Bryant Ranch Prepack, Inc. and manufactured by Amneal Pharmaceuticals.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.